Baxter's Generic Anesthetic Prevails In Patent Dispute With Abbott Labs
Baxter Pharmaceuticals has won a court's green light to begin marketing a generic version of the popular anesthetic Ultane after prevailing in a patent infringement lawsuit brought by drug originator Abbott...To view the full article, register now.
Already a subscriber? Click here to view full article